PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2019

Inhibition of xanthine oxidoreductase protects against contrast-induced renal tubular injury by activating adenosine monophosphate-activated protein kinase.

Mouse / Chemical/toxin

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 31560952 ↗2019Reported benefit

Inhibition of xanthine oxidoreductase protects against contrast-induced renal tubular injury by activating adenosine monophosphate-activated protein kinase.

MouseChemical/toxin

Model: Contrast-induced nephropathy induced with iohexol, with parallel in vitro studies in HK-2 proximal tubular cells

Febuxostat attenuated renal impairment and tubular injury in the mouse contrast-induced nephropathy model and reduced plasma and kidney xanthine oxidoreductase. It enhanced AMPK phosphorylation and inhibited Nox1, Nox2 and HIF-1alpha, lowering reactive oxygen species in vivo and in vitro and reduci…

Extraction: extract · Supplied extraction confidence: 0.6. Machine-extracted fields require source verification.